TODAY'S HEADLINES
Though half of melanoma patients with the BRAF mutation respond positively to treatment with BRAF inhibitors, most develop resistance to the drugs and experience disease progression. A new study suggests a drug used to treat malaria may help to block the pathway that causes this BRAF inhibitor resistance. » More
|
Infliximab, a monoclonal antibody, may be an effective treatment for children with Kawasaki disease, results of a recent study suggest. » More
|
ADVERTISEMENT
Discover the Difference - Dermatology EMR Webinar It's time to get specific! Join us for a webinar discussing how the top Dermatology specific EMR can optimize your office workflow. From robust functionality to increased patient engagement, NexTech will take you through the many benefits of a system dedicated to your specialty.
Reserve your spot today!
|
ADVERTISEMENT
Ace the Transition to ICD-10
Prepare your practice with the Ready10™ single-source solution and Lifeline two-part webinar series! Brought to you by Dermatology Times and Complete Practice Resources, this combo provides everything you need to know about successfully transitioning to ICD-10 while ensuring that your reimbursements continue.
Click to order today. »
|
Performing sentinel lymph node biopsies on melanoma patients can significantly prolong a patient's disease-free life by early detection of metastasis, according to a recent study. » More
|
|
|